Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| FoUI-985360 | Other Grant/Funding Number | Region Stockholm ALF |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This prospective observational study aims to investigate the ability of advanced ROTEM analysis using Principal Component Analysis (PCA) to detect early signs of disseminated intravascular coagulation (DIC) and trauma-induced coagulopathy (TIC) in hospitalized patients with sepsis or trauma. Standard coagulation tests and ROTEM measurements will be collected and analyzed in relation to clinical outcomes.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Trauma | Trauma alarm activated at hospital admission New Injury Severity Score (NISS) > 15 Transfer to hospital within 7 days of trauma with NISS > 15 | ||
| Sepsis | Meeting Sepsis-3 criteria Receipt of intravenous beta-lactam or aminoglycoside antibiotics within 48 hours of admission | ||
| Control | Patients undergoing elective surgery without expected coagulopathy |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Detection of abnormal coagulation clusters via PCA of ROTEM in trauma and sepsis patients | Detection of abnormal coagulation clusters via PCA of ROTEM in trauma and sepsis patients | Through study completion, an average of 2 years |
Not provided
Not provided
Inclusion Criteria:
Trauma patients:
Trauma alarm activated at hospital admission New Injury Severity Score (NISS) > 15 Transfer to hospital within 7 days of trauma with NISS > 15
Sepsis patients:
Meeting Sepsis-3 criteria Receipt of intravenous beta-lactam or aminoglycoside antibiotics within 48 hours of admission
Control group:
Patients undergoing elective surgery without expected coagulopathy
Exclusion Criteria:
Trauma patients:
Isolated chronic subdural hematoma No underlying traumatic event despite trauma alarm Age <18 years
Sepsis patients:
Age <18 years
Control patients:
Ongoing anticoagulant treatment Life-threatening illness (ASA IV-V) Age <18 years
Not provided
Not provided
Not provided
All patients in Stockhiolm Region
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Mattias Günther, MD PhD | Contact | +46812361000 | mattias.gunther@regionstockholm.se |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Region Stockholm | Recruiting | Stockholm | Sweden |
At this time, individual participant data (IPD) will not be shared due to privacy concerns, ethical considerations, and regulatory restrictions. The study involves sensitive patient data, including coagulation profiles and clinical outcomes, which are subject to strict data protection laws and institutional guidelines within Region Stockholm.
Additionally, data will be pseudoanonymized and stored on secure research servers, with access limited to the study team. While aggregate results will be published in peer-reviewed journals, sharing of raw IPD requires specific ethical and legal approvals, which are not currently in place for unrestricted access.
However, data access requests for collaborative research may be considered on a case-by-case basis, subject to approval by the relevant ethics committees and data protection authorities.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D018805 | Sepsis |
| D014947 | Wounds and Injuries |
| D020141 | Hemostatic Disorders |
| ID | Term |
|---|---|
| D007239 | Infections |
| D018746 | Systemic Inflammatory Response Syndrome |
| D007249 | Inflammation |
| D010335 | Pathologic Processes |
Not provided
Not provided
Not provided
Not provided
Not provided
Blood
| D013568 |
| Pathological Conditions, Signs and Symptoms |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D006474 | Hemorrhagic Disorders |
| D006402 | Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |